Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Healthscope

  • Home
  •  
  • Healthscope



  • Most Read
  • Latest Comments
  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    • News

  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

  • BTC Health drives earnings with product diversification to all major hospital operators
    BTC Health drives earnings with product diversification to all major hospital operators
    • News

  • Apiam Animal Health delivers record earnings, leverages animal data analytics and streamlines business to drive growth
    Apiam Animal Health delivers record earnings, leverages animal data analytics and streamlines business to drive growth
    • News

  • Apiam deploys revolutionary tick and flea preventative for Australian dog owners, a major growth driver for FY25
    Apiam deploys revolutionary tick and flea preventative for Australian dog owners, a major growth driver for FY25
    • News

  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

    Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health

    An investor syndicate featuring the well known names of Bruce Dixon and Vita Pepe have identified vet clinic operator Apiam Animal Health (ASX: AHX) as their next investment project after acquiring 13.44% of the Company.  On Wednesday, AHX shares were strangely active with 15% of the Company changing hands and no fanfare in a move

    Read More
    Public
  • BTC Health drives earnings with product diversification to all major hospital operators
    • News

    BTC Health drives earnings with product diversification to all major hospital operators

    It turns out that the departure of a significant partner can be a blessing in disguise, as demonstrated by medical distribution company BTC Health (ASX: BTC), which has delivered revenue and earnings growth through a series of measures implemented through FY24 to reduce their reliance on their previously biggest supplier.  In April 2023, BTC confirmed

    Read More
    Public
  • Alcidion engaged by Healthscope to predict your healthcare needs
    • News

    Alcidion engaged by Healthscope to predict your healthcare needs

    If Doctor Google can diagnose your current ailments, medical informatics company Alcidion (ASX: ALC) may soon be predicting your future needs after being engaged by Healthscope to develop a data and analytics solution.  The agreement, valued at $895,000 over three-years, will see the two companies work together as Healthscope seeks to transform the way healthcare

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.